Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence

Most patients with stable angina can be managed with lifestyle changes, especially smoking cessation and regular exercise, along with taking antianginal drugs. Randomised controlled trials show that antianginal drugs are equally effective and none of them reduced mortality or the risk of MI, yet gui...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Talla A Rousan, Udho Thadani
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2019
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/86df95ae493047dba7df85be84d05879
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:86df95ae493047dba7df85be84d05879
record_format	dspace
spelling	oai:doaj.org-article:86df95ae493047dba7df85be84d058792021-12-04T16:01:19ZStable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence10.15420/ecr.2018.26.11758-37641758-3756https://doaj.org/article/86df95ae493047dba7df85be84d058792019-01-01T00:00:00Zhttps://www.ecrjournal.com/articles/stable-angina-medical-therapy-management-guidelines-critical-review-guidelines-europeanhttps://doaj.org/toc/1758-3756https://doaj.org/toc/1758-3764Most patients with stable angina can be managed with lifestyle changes, especially smoking cessation and regular exercise, along with taking antianginal drugs. Randomised controlled trials show that antianginal drugs are equally effective and none of them reduced mortality or the risk of MI, yet guidelines prefer the use of beta-blockers and calcium channel blockers as a first-line treatment. The European Society of Cardiology guidelines for the management of stable coronary artery disease provide classes of recommendation with levels of evidence that are well defined. The National Institute for Health and Care Excellence (NICE) guidelines for the management of stable angina provide guidelines based on cost and effectiveness using the terms first-line and second-line therapy. Both guidelines recommend using low-dose aspirin and statins as disease-modifying agents. The aim of this article is to critically appraise the guidelines’ pharmacological recommendations for managing patients with stable angina.Talla A RousanUdho ThadaniRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENEuropean Cardiology Review , Vol 14, Iss 1, Pp 18-22 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Diseases of the circulatory (Cardiovascular) system RC666-701 Talla A Rousan Udho Thadani Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence
description	Most patients with stable angina can be managed with lifestyle changes, especially smoking cessation and regular exercise, along with taking antianginal drugs. Randomised controlled trials show that antianginal drugs are equally effective and none of them reduced mortality or the risk of MI, yet guidelines prefer the use of beta-blockers and calcium channel blockers as a first-line treatment. The European Society of Cardiology guidelines for the management of stable coronary artery disease provide classes of recommendation with levels of evidence that are well defined. The National Institute for Health and Care Excellence (NICE) guidelines for the management of stable angina provide guidelines based on cost and effectiveness using the terms first-line and second-line therapy. Both guidelines recommend using low-dose aspirin and statins as disease-modifying agents. The aim of this article is to critically appraise the guidelines’ pharmacological recommendations for managing patients with stable angina.
format	article
author	Talla A Rousan Udho Thadani
author_facet	Talla A Rousan Udho Thadani
author_sort	Talla A Rousan
title	Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence
title_short	Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence
title_full	Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence
title_fullStr	Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence
title_full_unstemmed	Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence
title_sort	stable angina medical therapy management guidelines: a critical review of guidelines from the european society of cardiology and national institute for health and care excellence
publisher	Radcliffe Medical Media
publishDate	2019
url	https://doaj.org/article/86df95ae493047dba7df85be84d05879
work_keys_str_mv	AT tallaarousan stableanginamedicaltherapymanagementguidelinesacriticalreviewofguidelinesfromtheeuropeansocietyofcardiologyandnationalinstituteforhealthandcareexcellence AT udhothadani stableanginamedicaltherapymanagementguidelinesacriticalreviewofguidelinesfromtheeuropeansocietyofcardiologyandnationalinstituteforhealthandcareexcellence
_version_	1718372805043552256

Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence

Ejemplares similares